. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Adrenergic alpha-Agonists/therapeutic useAdrenergic beta-Antagonists/therapeutic useAngiogenesis Inhibitors/therapeutic useAnti-Bacterial Agents/therapeutic useAntioxidants/therapeutic useCarbonic Anhydrase Inhibitors/therapeutic useCholinergic Agonists/therapeutic useConjunctivitis, Allergic/drug therapyConjunctivitis, Bacterial/drug therapyCyclosporine/therapeutic useDiuretics, Osmotic/therapeutic useDry Eye Syndromes/drug therapyEye Diseases/drug therapyGlaucoma/drug therapyGlucocorticoids/therapeutic useHumansImmunosuppressive Agents/therapeutic useMacular Degeneration/drug therapyMacular Degeneration/therapyOphthalmic Solutions/adverse effectsOphthalmic Solutions/therapeutic usePatient CompliancePatient SelectionPhotochemotherapyProstaglandins/therapeutic useTreatment OutcomeTriamcinolone Acetonide/therapeutic useVascular Endothelial Growth Factor A/antagonists & inhibitorsZinc/therapeutic use
Substances: See more » Adrenergic alpha-AgonistsAdrenergic beta-AntagonistsAngiogenesis InhibitorsAnti-Bacterial AgentsAntioxidantsCarbonic Anhydrase InhibitorsCholinergic AgonistsDiuretics, OsmoticGlucocorticoidsImmunosuppressive AgentsOphthalmic SolutionsProstaglandinsVascular Endothelial Growth Factor ACyclosporineTriamcinolone AcetonideZinc
Year: 2007 PMID: 17179899
Source DB: PubMed Journal: Treat Guidel Med Lett ISSN: 1541-2784